Table 1 Fluorescence and histopathological features of metastatic brain tumors and adjacent brain in 5-aminorevulinic acid (5-ALA) fluorescence-guided surgery
Case no. | Age sex | Origin of tumor | Histology | Fluorescence of tumor | Fluorescence of adjacent brain tissue | Brain invasion depth (mm) | Preoperative radiation treatment (month) | Preoperative chemotherapy |
|---|---|---|---|---|---|---|---|---|
1 | 54 F | Breast | Ad | No | Vague | No | − | + |
2 | 70 M | Colon | Ad | No | Vague | Positive (1.7) | − | − |
3 | 63 F | Lung | Ad | Heterogeneous | Vague | Positive (1.2) | − | − |
4 | 56 F | Breast | Ad | No | Vague | Positive (0.7) | − | + |
5 | 76 M | Rectum | Ad | Heterogeneous | Vague | Positive (1.8) | − | + |
6 | 38 M | Unknown | Ad | No | Vague | Positive (2.9) | − | + |
7 | 76 M | Bladder | Sq | No | Vague | No | − | − |
8 | 61 M | Lung | Ad | Heterogeneous | Vague | Positive (3.4) | − | + |
9 | 40 F | Breast | Ad | No | Vague | Positive (0.3) | − | + |
10 | 61 M | Salivary duct | Ad | No | Vague | Positive (0.8) | WBRT (3) | − |
11 | 10 M | Bone | OS | No | No | Positive (0.2) | − | − |
12 | 54 F | Breast | Ad | No | No | No | SRS (27) | + |
13 | 46 M | Lung | Ad | Heterogeneous | Vague | Positive (1.6) | SRS (8) | + |
14 | 67 M | Colon | Ad | No | Vague | Positive (2.0) | SRS (3) | − |
15 | 38 M | Unknown | Ad | No | Vague | Positive (0.3) | − | − |
16 | 49 M | Rectal | Ad | Heterogeneous | Vague | No | − | + |